Simultaneous uncoupled expression and purification of the Dengue virus NS3 protease and NS2B co-factor domain

被引:18
|
作者
Shannon, A. E. [1 ]
Chappell, K. J. [1 ]
Stoermer, M. J. [2 ]
Chow, S. Y. [2 ]
Kok, W. M. [2 ]
Fairlie, D. P. [2 ]
Young, P. R. [1 ,2 ]
机构
[1] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia
[2] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld 4072, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
Dengue virus; Protease; NS2B-NS3; Cofactor inhibitor; YELLOW-FEVER VIRUS; WEST-NILE-VIRUS; ENZYMATIC CHARACTERIZATION; STRUCTURAL PROTEINS; VIRAL REPLICATION; CLEAVAGE SITES; IN-VITRO; POLYPROTEIN; MUTAGENESIS; FLAVIVIRUS;
D O I
10.1016/j.pep.2015.11.022
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Dengue Virus (DENV) infection is responsible for the world's most significant insect-borne viral disease. Despite an increasing global impact, there are neither prophylactic nor therapeutic options available for the effective treatment of DENV infection. An attractive target for antiviral drugs is the virally encoded trypsin-like serine protease (NS3pro) and its associated cofactor (NS2B). The NS2B NS3pro complex is responsible for cleaving the viral polyprotein into separate functional viral proteins, and is therefore essential for replication. Recombinant expression of an active NS2B-NS3 protease has primarily been based on constructs linking the C-terminus of the approximately 40 amino acid hydrophilic cofactor domain of NS2B to the N-terminus of NS3pro via a flexible glycine linker. The resulting complex can be expressed in high yield, is soluble and catalytically active and has been used for most in vitro screening, inhibitor, and X-ray crystallographic studies over the last 15 years. Despite extensive analysis, no inhibitor drug candidates have been identified yet. Moreover, the effect of the artificial linker introduced between the protease and its cofactor is unknown. Two alternate methods for bacterial expression of non-covalently linked, catalytically active, NS2B-NS3pro complex are described here along with a comparison of the kinetics of substrate proteolysis and binding affinities of substrate-based aldehyde inhibitors. Both expression methods produced high yields of soluble protein with improved substrate proteolysis kinetics and inhibitor binding compared to their glycine-linked equivalent. The non-covalent association between NS2B and NS3pro is predicted to be more relevant for examining inhibitors that target cofactor-protease interactions rather than the protease active site. Furthermore, these approaches offer alternative strategies for the high yield co-expression of other protein assemblies. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:124 / 129
页数:6
相关论文
共 50 条
  • [1] Novel Dengue Virus NS2B/NS3 Protease Inhibitors
    Wu, Hongmei
    Bock, Stefanie
    Snitko, Mariya
    Berger, Thilo
    Weidner, Thomas
    Holloway, Steven
    Kanitz, Manuel
    Diederich, Wibke E.
    Steuber, Holger
    Walter, Christof
    Hofmann, Daniela
    Weissbrich, Benedikt
    Spannaus, Ralf
    Acosta, Eliana G.
    Bartenschlager, Ralf
    Engels, Bernd
    Schirmeister, Tanja
    Bodem, Jochen
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (02) : 1100 - 1109
  • [2] Molecular mechanism of the Dengue virus NS3/NS2b protease
    Lima, Maria Carolina
    Seabra, Gustavo
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [3] Molecular Dynamics of the Dengue Virus NS3/NS2b Protease
    Lima, Maria Carolina P.
    Seabra, Gustavo M.
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 734A - 734A
  • [4] Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors
    Leung, D
    Schroder, K
    White, H
    Fang, NX
    Stoermer, MJ
    Abbenante, G
    Martin, JL
    Young, PR
    Fairlie, DP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (49) : 45762 - 45771
  • [5] Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side
    Lin, Kuan-Hung
    Ali, Akbar
    Rusere, Linah
    Soumana, Djade I.
    Yilmaz, Nese Kurt
    Schiffer, Celia A.
    JOURNAL OF VIROLOGY, 2017, 91 (10)
  • [6] IN SILICO DRUG DESIGNING STUDIES ON DENGUE VIRUS NS2B/NS3 PROTEASE
    Sushmitha, H. S.
    Sathyamurthy, Balasubramanian
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (08): : 7784 - 7790
  • [7] Molecular Dynamics of the Dengue Virus NS3/NS2B Protease in Presence of Inhibitor or Substrate
    Lima, Maria Carolina P.
    Seabra, Gustavo de Miranda
    BIOPHYSICAL JOURNAL, 2014, 106 (02) : 261A - 261A
  • [8] The two-component protease NS2B-NS3 of dengue virus type 2:: Cloning, expression in Escherichia coli and purification of the NS2B, NS3(pro) and NS2B-NS3 proteins
    Champreda, V
    Khumthong, R
    Subsin, B
    Angsuthanasombat, C
    Panyim, S
    Katzenmeier, G
    JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2000, 33 (04): : 294 - 299
  • [9] Molecular dynamics simulation and virtual screening for inhibitors of dengue virus NS2B/NS3 protease
    Wichapong, Kanin
    Pianwanit, Somsak
    Sippl, Wolfgang
    Kokpol, Sirirat
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [10] In silico identification of novel allosteric inhibitors of Dengue virus NS2B/NS3 serine protease
    Da Costa, Renato A.
    Da Rocha, Joao A. P.
    Pinheiro, Alan S.
    Da Costa, Andreia S. S.
    Da Rocha, Elaine C. M.
    Josino, Luiz P. C.
    Goncalves, Arlan da silva
    Lima, Anderson H. L.
    Brasil, Davi S. B.
    JOURNAL OF THE SERBIAN CHEMICAL SOCIETY, 2022, 87 (06) : 693 - 706